Back to results
US 2023/0265409 A1Published application
Polypeptide having cephalosporin c acylase activity and use thereof
AssigneeAmicogen, Inc.
InventorsZhe PIAO, Eun Seon WANG, Hong Xian LI, Mi Kyoung LEE, Ah Reum SON, Su Jin LIM
Life of this patent
Estimating the term…
Abstract
Disclosed herein are a polypeptide having cephalosporin C(CPC) acylase activity and a use thereof. More specifically, a mutant CPC acylase comprising a point mutation introduced thereinto, thereby exhibiting improved enzymatic activity and/or stability, and a use of the mutant CPC acylase for producing 7-aminocephalosporanic acid (7-ACA), are provided.
Claims17
A mutant cephalosporin C (CPC) acylase, derived from a CPC acylase comprising an alpha-subunit and a beta-subunit,
- wherein the mutant CPC acylase comprises a mutation by at least one amino acid substitution selected from the group consisting of:
- substitution of alanine at position 11 in the alpha-subunit of SEQ ID NO:
- 3 (A11α) with asparagine (N), proline (P), glutamine (Q), isoleucine (I), valine (V), or leucine (L);
- substitution of glycine at position 24 in the alpha-subunit of SEQ ID NO:
- 3 (G24α) with an amino acid different from the original amino acid residue;
- substitution of alanine at position 136 in the beta-subunit of SEQ ID NO:
- 4 (A136β) with an amino acid different from the original amino acid residue;
- substitution of isoleucine at position 179 in the beta-subunit of SEQ ID NO:
- 4 (I179β) with an amino acid different from the original amino acid residue;
- and
- substitution of histidine at position 453 in the beta-subunit of SEQ ID NO:
- 4 (H453β) with an amino acid different from the original amino acid residue.
9 more elements
Dependencies are inferred from the claim text.